Heparin Sodium Injection, Solution
NDC Package 55154-9589-5

11-digit billing NDC: 55154958905

Package Information

Heparin Sodium injection is indicated for: •Prophylaxis and treatment of venous thrombosis and pulmonary embolism; •Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; •Atrial fibrillation with embolization; •Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); •Prevention of clotting in arterial and cardiac surgery; •Prophylaxis and treatment of peripheral arterial embolism. This formulation utilizes a injection, solution delivery system. Marketed by Cardinal Health 107, Llc, this product is identified by NDC 55154-9589 and is authorized under FDA application NDA017029.

Identification & Billing

NDC Package Code
55154-9589-5
Package Description
5 VIAL in 1 BAG / .5 mL in 1 VIAL
Product Code
11-Digit Billing Format
55154958905
RxNorm Crosswalk
  • RxCUI: 1361615 - heparin sodium, porcine 5000 UNT/ML Injectable Solution
  • RxCUI: 1658634 - heparin sodium, porcine 5000 UNT in 0.5 mL Injection
  • RxCUI: 1658634 - 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection
  • RxCUI: 1658634 - heparin sodium, porcine 5000 UNT per 0.5 ML Injection

Clinical Specifications

Proprietary Name
Heparin Sodium
Non-Proprietary Name
Heparin Sodium
Substance Name
Heparin Sodium
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
Usage Information
Heparin Sodium Injection is indicated for: •Prophylaxis and treatment of venous thrombosis and pulmonary embolism; •Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; •Atrial fibrillation with embolization; •Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); •Prevention of clotting in arterial and cardiac surgery; •Prophylaxis and treatment of peripheral arterial embolism. •Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures.

Regulatory & Marketing

Labeler Name
Cardinal Health 107, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA017029
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-12-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55154-9589-5 identifies a specific commercial package of 5 vial in 1 bag / .5 ml in 1 vial of Heparin Sodium, a human prescription drug labeled by Cardinal Health 107, Llc. This injection, solution is formulated for intravenous; subcutaneous use and contains heparin sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cardinal Health 107, Llc on May 12, 2026. The current certification is valid through December 31, 2027.

How is this Cardinal Health 107, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154958905. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55154-9589-5
11-Digit CMS (5-4-2)
55154-9589-05

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.